Relatedness of different immune response to vaccine Throughout study [clinicaltrials_resource:ad59a31502fb5eaca15ad3ae27870c38]
MRKAd5 HIV-1 gag/pol/nef vaccine administered as 1 ml in either deltoid at study entry and Weeks 4 and 26
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Relatedness of different immune response to vaccine Throughout study [clinicaltrials_resource:ad59a31502fb5eaca15ad3ae27870c38]
MRKAd5 HIV-1 gag/pol/nef vaccine administered as 1 ml in either deltoid at study entry and Weeks 4 and 26
Bio2RDF identifier
ad59a31502fb5eaca15ad3ae27870c38
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ad59a31502fb5eaca15ad3ae27870c38
measure [clinicaltrials_vocabulary:measure]
Relatedness of different immune response to vaccine
time frame [clinicaltrials_vocabulary:time-frame]
Throughout study
description
MRKAd5 HIV-1 gag/pol/nef vacci ...... study entry and Weeks 4 and 26
identifier
clinicaltrials_resource:ad59a31502fb5eaca15ad3ae27870c38
title
Relatedness of different immune response to vaccine Throughout study
@en
type
label
Relatedness of different immun ...... 9a31502fb5eaca15ad3ae27870c38]
@en